High level of expression of a protective antigen of schistosomes in Saccharomyces cerevisiae.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 2694678)

Published in Yeast on March 14, 1990

Authors

G Loison1, A Vidal, A Findeli, C Roitsch, J M Balloul, Y Lemoine

Author Affiliations

1: Transgene S.A., Strasbourg, France.

Articles by these authors

Chromogenic identification of genetic regulatory signals in Bacillus subtilis based on expression of a cloned Pseudomonas gene. Proc Natl Acad Sci U S A (1983) 5.33

Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts. Biophys J (2002) 2.76

The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71

Seismicity remotely triggered by the magnitude 7.3 landers, california, earthquake. Science (1993) 2.61

Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Res (1983) 2.56

The regulation of urea amidolyase of Saccharomyces cerevisiae: mating type influence on a constitutivity mutation acting in cis. Mol Gen Genet (1978) 2.17

A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA. Mol Cell Biol (2000) 2.08

[Anesthesia for cesarean section in patients with mitral valve prolapse]. Rev Esp Anestesiol Reanim (1996) 2.05

HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int (2006) 1.85

Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast. Gene (1992) 1.57

The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. EMBO J (1988) 1.55

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51

The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J Biol Chem (1996) 1.50

Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod (1994) 1.50

Molecular cloning of a protective antigen of schistosomes. Nature (1987) 1.49

The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin Cancer Res (2013) 1.47

Cloning and characterization of the Bacillus sphaericus genes controlling the bioconversion of pimelate into dethiobiotin. Gene (1990) 1.42

Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem (1994) 1.41

Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res (1992) 1.40

A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39

Adaptation of the Photosynthetic Apparatus in Maize Leaves as a Result of Nitrogen Limitation : Relationships between Electron Transport and Carbon Assimilation. Plant Physiol (1990) 1.30

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol (1997) 1.23

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene (2010) 1.16

Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol (1991) 1.15

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin. Oncogene (2011) 1.13

Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus. Gene Ther (2008) 1.12

Cloning and nucleotide sequence of the phosphoenolpyruvate carboxylase-coding gene of Corynebacterium glutamicum ATCC13032. Gene (1989) 1.11

Isolation and characterization of chromosomal promoters of Streptococcus salivarius subsp. thermophilus. Appl Environ Microbiol (1991) 1.10

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunol Immunother (2000) 1.10

Consequence of Absence of Nitrate Reductase Activity on Photosynthesis in Nicotiana plumbaginifolia Plants. Plant Physiol (1987) 1.10

Nucleotide sequence of the bioH gene of Escherichia coli. Nucleic Acids Res (1989) 1.10

Characterization of the biotin biosynthesis pathway in Saccharomyces cerevisiae and evidence for a cluster containing BIO5, a novel gene involved in vitamer uptake. Gene (1999) 1.08

Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol Cell Biol (1993) 1.06

Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics (2003) 1.06

On the presence and role of a molecule of chlorophyll a in the cytochrome b6 f complex. J Biol Chem (1997) 1.03

Cloning of the biotin synthetase gene from Bacillus sphaericus and expression in Escherichia coli and Bacilli. Gene (1989) 1.03

Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis. Blood (1989) 1.03

Investigation of the first step of biotin biosynthesis in Bacillus sphaericus. Purification and characterization of the pimeloyl-CoA synthase, and uptake of pimelate. Biochem J (1992) 1.03

An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses. Vaccine (2007) 1.02

To be free or not: the fate of pimelate in Bacillus sphaericus and in Escherichia coli. Mol Microbiol (1996) 1.01

Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem J (1998) 1.01

Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides. J Clin Microbiol (1990) 0.97

Isolation of Bacillus sphaericus biotin synthesis control mutants: evidence for transcriptional regulation of bio genes. Gene (1991) 0.96

Altered specificities of genetically engineered alpha 1 antitrypsin variants. Protein Eng (1989) 0.95

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J Immunother (2001) 0.94

In vitro synthesis of a 28 kilodalton antigen present on the surface of the schistosomulum of Schistosoma mansoni. Mol Biochem Parasitol (1985) 0.94

[Primary structure of human protein pS2]. C R Acad Sci III (1988) 0.93

The role of spiral CT for the assessment of the intracranial circulation in suspected brain-death. J Neuroradiol (2006) 0.93

Modified vaccinia virus Ankara as a vector for suicide gene therapy. Cancer Gene Ther (2007) 0.93

Variations in protein expression related to human eosinophil heterogeneity. J Immunol (1989) 0.93

Potential usefulness of bacteriophages that infect Bacteroides fragilis as model organisms for monitoring virus removal in drinking water treatment plants. Appl Environ Microbiol (1995) 0.92

Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. J Immunother Emphasis Tumor Immunol (1993) 0.91

Characterization of multiple acylation sites on a recombinant protein by electrospray mass spectrometry. Biol Mass Spectrom (1993) 0.90

Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen. J Immunol (1989) 0.90

TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene (1998) 0.89

Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. Fertil Steril (1993) 0.89

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther (2000) 0.89

Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides. J Immunol (1988) 0.89

LEFPS1, a tomato farnesyl pyrophosphate gene highly expressed during early fruit development. Plant Physiol (2000) 0.89

Investigation of prevalence and risk factors for Campylobacter in broiler flocks at slaughter: results from a UK survey. Epidemiol Infect (2012) 0.88

Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis. Exp Hematol (1991) 0.88

Effects of the aqueous extract of Bryothamnion triquetrum on chemical hypoxia and aglycemia-induced damage in GT1-7 mouse hypothalamic immortalized cells. Phytomedicine (2005) 0.88

Molecular characterization of hybrid Tbp2 proteins from Neisseria meningitidis. Mol Microbiol (1996) 0.88

Improved liquid chromatographic method for the analysis of photosynthetic pigments of higher plants. J Chromatogr A (2000) 0.88

Sequence-specific deamidation: isolation and biochemical characterization of succinimide intermediates of recombinant hirudin. Biochemistry (1993) 0.87

Grain size effect on trace metals distribution in sediments from two coastal areas of Chile. Bull Environ Contam Toxicol (1996) 0.87

Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase. Mol Biochem Parasitol (1990) 0.87

[Gender differences in cognitive functions and influence of sex hormones]. Actas Esp Psiquiatr (2006) 0.86

Survival of parvalbumin-immunoreactive neurons in the gerbil hippocampus following transient forebrain ischemia does not depend on HSP-70 protein induction. Brain Res (1995) 0.86

Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. J Gen Virol (1990) 0.86

Determination of disulfide bridges in natural and recombinant insect defensin A. Eur J Biochem (1991) 0.86

Isolation of recombinant partial gag gene product p18 (HIV-1Bru) from Escherichia coli. J Chromatogr (1989) 0.86

Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats. Thromb Haemost (1990) 0.86

In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection. Gene Ther (2011) 0.85

[Antioxidants and diabetes mellitus: review of the evidence]. Nutr Hosp (2011) 0.85

Development of an efficient spheroplast transformation procedure for S. thermophilus: the use of transfection to define a regeneration medium. Biochimie (1988) 0.85

[Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure]. Aten Primaria (2000) 0.84

Astaxanthin accumulation in Haematococcus requires a cytochrome P450 hydroxylase and an active synthesis of fatty acids. FEBS Lett (2001) 0.84

Necrotizing retinitis and cerebral vasculitis due to varicella-zoster virus in patients infected with the human immunodeficiency virus. Clin Infect Dis (1993) 0.84

Salicylate-selective electrode based on a biomimetic guanidinium ionophore. Anal Chem (1997) 0.83

Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry (2007) 0.83

Characterization of the deamidated forms of recombinant hirudin. Biochemistry (1992) 0.83

Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiae. Biochemistry (1989) 0.83

Resistance of Legionella to disinfection in hot water distribution systems. Water Sci Technol (2005) 0.82

The production of biotin by recombinant strains of Escherichia coli. J Chem Technol Biotechnol (1991) 0.82

A new signal peptide useful for secretion of heterologous proteins from yeast and its application for synthesis of hirudin. Gene (1992) 0.82

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2. Cancer Immunol Immunother (2001) 0.81

Milky-white pleural effusion complicating peripherically inserted central venous catheter for total parenteral nutrition. Eur J Clin Nutr (2005) 0.81

Point mutations modifying the thrombin inhibition kinetics and antithrombotic activity in vivo of recombinant hirudin. Protein Eng (1989) 0.81

Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux and Bryothamnion triquetrum (S.G.Gmelim) Howe on hydrogen peroxide and methyl mercury-induced oxidative stress in GT1-7 mouse hypothalamic immortalized cells. Phytomedicine (2003) 0.80

Application of electrospray mass spectrometry to the characterization of recombinant proteins up to 44 kDa. Biomed Environ Mass Spectrom (1990) 0.80

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment. Hum Gene Ther (2000) 0.80

Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II. Eur J Biochem (1991) 0.79

Two recombinant human interferon-beta 1a pharmaceutical preparations produce a similar transcriptional response determined using whole genome microarray analysis. Int J Clin Pharmacol Ther (2008) 0.79

Whole genome analysis of the action of interferon-beta. Int J Clin Pharmacol Ther (2009) 0.79

Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. J Clin Invest (1987) 0.79